Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00360490 · ClinicalTrials.gov registry record · Phase 3

Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)

A Phase 3 study of Menorrhagia, sponsored by Bayer.

Completed
Registry status
Phase 3
Development phase
165
Enrollment target
20
Study locations

NCT00360490 is a Phase 3 study of Menorrhagia that has completed, run by Bayer. The registered enrollment target is 165 participants, below the 212-participant average among 10 other Menorrhagia trials with a reported enrollment target (22% lower). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00360490, a Phase 3 study of Menorrhagia, has completed, sponsored by Bayer.

COMPLETED
Registry status
Phase 3
Development phase
165 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to determine whether the levonorgestrel-releasing intrauterine system is effective in decreasing menstrual blood loss.

Conditions Studied

Menorrhagia

Interventions

  • DRUG Medroxyprogesterone acetate
  • DRUG Levonorgestrel IUS (Mirena, BAY86-5028)

Study Locations (20)

California

  • - Beverly Hills
  • - Carmichael
  • - San Diego
  • - San Diego
  • - Santa Monica
  • - Torrance

Florida

  • - Boynton Beach
  • - Jacksonville
  • - West Palm Beach

Indiana

  • - Newburgh
  • - South Bend

Louisiana

  • - Amite
  • - Marrero

Arizona

  • - Tucson

Colorado

  • - Littleton

Idaho

  • - Boise

Illinois

  • - Chicago

Trial Details

FieldValue
Enrollment Target 165 participants
Start Date 2006-07
Est. Completion 2008-06
Phase Phase 3

Sponsor

Bayer

591 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00360490

The ClinicalTrials.gov registry entry for NCT00360490 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 212-participant average among 10 other Menorrhagia trials with a reported enrollment target (22% lower). The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Menorrhagia appearing as the primary indexed condition, and to 2 interventions - of which Medroxyprogesterone acetate is the first listed.

NCT00360490 reports 20 study locations spanning 11 distinct geographic areas - top geographies include California, Florida, Indiana.

Frequently Asked Questions

What is clinical trial NCT00360490 about?

NCT00360490 is a clinical study titled "Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)". The purpose of this study is to determine whether the levonorgestrel-releasing intrauterine system is effective in decreasing menstrual blood loss.

What is the current status of trial NCT00360490?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 165 participants. The study started on 2006-07. Estimated completion is 2008-06.

What conditions does trial NCT00360490 study?

This clinical trial studies the following conditions: Menorrhagia.

What interventions are being tested in trial NCT00360490?

The interventions under investigation include: Medroxyprogesterone acetate (DRUG), Levonorgestrel IUS (Mirena, BAY86-5028) (DRUG).

Who is sponsoring clinical trial NCT00360490?

This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00360490 being conducted?

This trial has 20 study locations across Arizona, California, Colorado, Florida, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Menorrhagia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Menorrhagia

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.